Karyopharm Therapeutics Inc at Jefferies Healthcare Conference (Virtual) Transcript
It's my pleasure that I'd like to welcome Richard Paulson, the CEO of Karyopharm. Thanks for joining us today, Richard.
Good morning, Maury. Great to be here.
We're going to do a fireside chat. So maybe to start off, if you want to provide a 1-minute intro to Karyopharm, and maybe talk about some of the key catalysts at.
Sure. I think, Maury, I mean, as you know, and I think as many investors know, Karyopharm is now a fully commercial-stage organization, really founded in science and founded in development of the selective inhibition of nuclear export. And we are the leader in that with selinexor and our next-generation molecule eltanexor, with 3 approved
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
